Ironwood begins Phase III trial of linaclotide 72mcg in adults with chronic idiopathic constipation

US-based Ironwood Pharmaceuticals has started a Phase III clinical trial in the US evaluating once-daily linaclotide 72mcg capsule in adults suffering from chronic idiopathic constipation (CIC).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news